KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 42,402 Value ($000) $1,749 Avg Close $40.11 Range $35.20 - $44.42

Q3 2025

Shares 55,519 Value ($000) $2,156 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 104,705 Value ($000) $2,897 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 55,976 Value ($000) $1,243 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 56,691 Value ($000) $1,121 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 44,229 Value ($000) $1,105 Avg Close $24.36 Range $17.38 - $27.92

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	42,402	$1,749	$40.11	$35.20 - $44.42
Q3 2025	55,519	$2,156	$32.49	$26.27 - $39.00
Q2 2025	104,705	$2,897	$25.46	$18.25 - $30.69
Q1 2025	55,976	$1,243	$20.58	$17.82 - $24.31
Q4 2024	56,691	$1,121	$22.82	$19.47 - $28.15
Q3 2024	44,229	$1,105	$24.36	$17.38 - $27.92